Reliable Rx Pharmacy LLC, a compounding pharmacy operating under a state pharmacy license, was the subject of a coordinated action by the Drug Enforcement Administration and state pharmacy regulators after investigators found the pharmacy was dispensing compounded controlled substance medications — including anabolic steroids, testosterone preparations, and stimulant compounds — to customers who did not have valid prescriptions from physicians who had established genuine patient-physician relationships and conducted the clinical evaluation required to prescribe controlled substances.DOCUMENTED
Compounding pharmacies that prepare customized drug formulations for individual patients perform a legitimate and regulated function in the pharmaceutical system. However, a pharmacy operating under a compounding license must comply with the same controlled substance prescription requirements that apply to conventional pharmacies — a compounding operation does not exempt a pharmacy from the requirement that controlled substance dispensing be based on a valid prescription from a practitioner who has conducted a good-faith evaluation of the patient and determined that the controlled substance is medically necessary. When a compounding pharmacy accepts prescriptions that do not meet these standards, it is effectively operating as a source of controlled substances outside the regulatory framework designed to prevent diversion and abuse.REVIEWED
- Reliable Rx dispensed compounded testosterone, anabolic steroids, and stimulant formulations to customers across multiple states through mail order
- Investigators found that a significant portion of the prescriptions dispensed came from prescribers who had not conducted clinical evaluations consistent with legitimate prescribing
- Some prescriptions were issued through online consultation platforms that investigators found did not meet the standard for establishing a valid patient-physician relationship
- The pharmacy marketed its compounded controlled substance products directly to consumers in a manner that regulators found constituted marketing of controlled substances outside legitimate medical channels
- DEA registration revocation and state pharmacy license suspension were among the enforcement actions taken
The Prescription Validity Problem
A valid controlled substance prescription must be issued by a practitioner who is authorized to prescribe controlled substances in the applicable jurisdiction, who has established a patient-physician relationship through examination of the patient, and who has determined in the course of that examination that the patient has a condition for which the controlled substance is medically indicated. The examination requirement can in some circumstances be met through a telehealth encounter that complies with applicable federal and state telehealth prescribing rules — but not through a brief online questionnaire without live physician review or a prescription issued without any substantive clinical evaluation of the patient.REVIEWED
Investigators found that Reliable Rx accepted prescriptions from online consultation services that, on examination, did not meet these standards. In several documented cases, the prescriptions were issued to customers who had self-reported symptoms through an online form without a synchronous examination by a physician — a process that investigators found did not constitute a good-faith clinical evaluation adequate to support a legitimate controlled substance prescription. The pharmacy's acceptance of these prescriptions without adequate review of their validity made it a conduit for controlled substance distribution outside legitimate medical channels.DOCUMENTED
Direct-to-Consumer Marketing of Controlled Substances
The investigation also found that Reliable Rx engaged in direct-to-consumer marketing that promoted its compounded testosterone and anabolic steroid preparations in ways that regulators found were inconsistent with the restriction of controlled substance dispensing to legitimate medical purposes. The pharmacy's online presence and marketing communications described performance and aesthetic benefits of the compounds — muscle mass, energy, body composition — in terms that positioned the products for use consistent with performance enhancement rather than with medical treatment of diagnosed conditions.DOCUMENTED
Marketing controlled substances in terms that emphasize non-medical performance benefits implicitly invites customers to seek the products for reasons other than a legitimate medical need — undermining the gatekeeping function of the prescription requirement. The DEA found that the pharmacy's marketing conduct was consistent with a pattern of distributing controlled substances outside legitimate medical channels, which is among the most serious violations of the Controlled Substances Act framework.DOCUMENTED
The pharmacy's marketing materials described testosterone and hormone preparations in terms focused on aesthetic and athletic performance outcomes — language regulators found was inconsistent with promotion of a prescription medication for medical indications and consistent with marketing controlled substances for non-medical use.
Interstate Mail Order Operation
Reliable Rx operated as a mail-order pharmacy, dispensing to customers across multiple states. The multi-state operation created a complex enforcement picture, because pharmacy licensing is state-by-state while the DEA registration required to handle controlled substances is federal. The pharmacy held the necessary licenses and registrations for its home state, but its multi-state mail order operations created questions about whether it was operating legally under the pharmacy laws of every state in which it had customers — questions that state regulators in several customer states pursued in coordination with the federal enforcement action.DOCUMENTED
Mail-order controlled substance pharmacies are a category that has received sustained regulatory attention as online consultation platforms have proliferated and as consumer demand for hormone preparations, stimulants, and other controlled substances through convenient online channels has grown. The telehealth prescribing expansion during the COVID-19 public health emergency, while addressing genuine access needs, also created opportunities for pharmacy operations that exploit the remote prescribing model to dispense controlled substances with less rigorous prescription validation than the regulatory framework intends.REVIEWED
Enforcement Outcomes
The DEA initiated proceedings to revoke Reliable Rx's DEA registration — the federal certification required to handle controlled substances — and state pharmacy regulators suspended the pharmacy's state license pending the outcome of the enforcement action. Without the DEA registration, a pharmacy cannot legally possess or dispense any scheduled controlled substance, effectively ending the ability to operate as a pharmacy in the controlled substance space. The principals of the pharmacy also face individual liability in connection with the controlled substance distribution findings, as the responsible pharmacist-in-charge is subject to personal DEA registration consequences in addition to any corporate liability.DOCUMENTED
Patients who received compounded controlled substance prescriptions through online consultation services and who believe they did not receive a genuine clinical evaluation before their prescription was issued should discuss their treatment with a physician in an in-person practice. Individuals who purchased testosterone, anabolic steroids, or other compounded controlled substances from mail-order pharmacies and have concerns about the legality of those transactions are encouraged to consult with a healthcare attorney. Watchdog Journal's tip channel at /tips is available for individuals with knowledge of similar operations.
Sources behind this report
Have documents relevant to this story? Reach us through our tips channel.